Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma

Fig. 2

Tumour response in a patient with liver-only metastases from primary pancreatic adenocarcinoma. a Contrast-enhanced CT scan prior to SIRT + 5FU. b) Follow-up contrast-enhanced CT scan 3 months post-SIRT + 5FU, and prior to gemcitabine, demonstrates a partial response (40 % reduction in hepatic tumour burden), as assessed according to RECIST v1.0

Back to article page